Does Macquarie rate AUB Group shares a buy after the deal fell through?

The AUB Group takeover deal is dead, but the business is very much alive, with Macquarie still seeing good value in the company.

Key points
  • The deal for private equity firms to acquire AUB Group for $45 per share has collapsed. 
  • Despite that, Macquarie still think there is good value in AUB Group and has placed a $37.40 price target on the company. 
  • This implies approximately 19% upside from the current share price. 

When a takeover bid collapses, investors usually see it as bad news. But in the case of AUB Group Ltd (ASX: AUB) and its failed takeover by private equity suitors, it may actually be good news of sorts.

Macquarie's latest research suggests that it might finally be back to business for the insurance broker network.

A few days ago, AUB confirmed that EQT and CVC had terminated discussions regarding a potential takeover. The suitors decided not to proceed with a binding proposal to buy the company for $45 per share.

For shareholders who were eyeing that $45 payout, it's a hard one to take because AUB Group shares are currently trading at $31.40 per share.

The analysts at Macquarie, however, certainly seem to see an opportunity here.

Two people shake hands making a deal about green energy.

Image source: Getty Images

Back to business

In a research note released immediately following the news, Macquarie maintained an outperform rating on AUB Group, assigning a 12-month price target of $37.40 to the shares.

Macquarie's message is simple: it's "back to business".

Even without a takeover premium, Macquarie believes the fundamentals of AUB are rock solid. They note that AUB is executing well across multiple earnings growth opportunities and the company has a history of delivering consistent organic growth, supplemented by smart acquisitions.

Why Macquarie is bullish

There are three main reasons Macquarie thinks the stock is a buy at today's prices:

  1. The Valuation Gap: AUB is currently trading at a forward price-to-earnings (P/E) ratio of roughly 15.6x. That is significantly cheaper than its historical average of 18.3x and cheaper than its recent average of 19.6x. In short, the stock looks like a bargain compared to its own history.
  2. Broking Strength: Despite fears that insurance premium rates might soften, AUB continues to grow. In the Australian broking segment, average income per client actually increased by 8.4% recently. They are squeezing more value out of existing relationships.
  3. The International Opportunity: The Tysers (International) business is the sleeping giant here. Current EBIT margins are around 25%, but AUB is targeting 32% over the medium term. If they hit that target, it implies significant earnings upside that Macquarie feels isn't fully baked into the current share price.

Risks

There are still risks, however, to investing in AUB Group, and Macquarie points out that poor M&A execution remains a key risk. When growth relies partly on buying other companies, you have to buy the right ones at the right price and integrate them well into your business. Additionally, if the premium rate cycle turns faster than expected, it could put pressure on earnings.

Foolish bottom line

The AUB Group takeover deal is dead, but the business is very much alive. With a price target of $37.40, offering a potential upside of approximately 19% from the current price, Macquarie suggests that AUB Group represents a good investment opportunity for patient investors.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Aub Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »

Woman tying up her shoelaces before a run.
Broker Notes

Buy, hold, sell: Coles, Wesfarmers, CSL shares

It's a new week and we've got new ratings from the experts.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two male ASX investors and executives wearing dark coloured suits sit at a table holding their mobile phones discussing the highest trading ASX 200 shares today
Broker Notes

Buy, hold, sell: Resmed, Goodman Group, CBA shares

We review three fresh buy, hold, and sell calls from John Athanasiou at Red Leaf Securities.

Read more »

colleagues on a lunch break looking at iPhone
Broker Notes

Top brokers name 3 ASX shares to buy now

Here's what brokers are recommending as buys this week.

Read more »

Woman with her fingers crossed and eyes shut.
Broker Notes

7 ASX 200 shares in the buy zone as optimism returns to the market: experts

Brokers reaffirmed their buy calls on Liontown, Rio Tinto, Xero, and others this week.

Read more »

ASX shares broker ratings represented by three different coloured buttons.
Broker Notes

6 ASX shares upgraded and downgraded by the experts this week

Brokers have changed their ratings and 12-month price targets on Qantas, Codan, and others. 

Read more »